About Bloomage Biotechnology
Bloomage Biotechnology is a company based in Jinan (China) founded in 1998.. The company has 4,440 employees as of December 31, 2024. Bloomage Biotechnology has completed 1 acquisition, including Beijing Yierkang Bioengineering. Bloomage Biotechnology operates in a competitive market with competitors including Fidia Farma, Lifecore, Contipro, Qingdao Kangyuan Pharmaceutica and Altergon Italia, among others.
- Headquarter Jinan, China
- Employees 4440 as on 31 Dec, 2024
- Stage Public
-
Sectors
Chemicals & MaterialsHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bloomage Biotechnology Corp. Ltd. Class A
-
Annual Revenue
$727.46 M (USD)-11.71as on Dec 31, 2024
-
Net Profit
$23.87 M (USD)-70.59as on Dec 31, 2024
-
EBITDA
$75.9 M (USD)-35.61as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
4440
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Bloomage Biotechnology
Bloomage Biotechnology is a publicly listed company on the SSE with ticker symbol 688363 in China, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Bloomage Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Bloomage Biotechnology
Bloomage Biotechnology has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Beijing Yierkang Bioengineering. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Manufacturer of artificial bone and collagen sponge
|
1997 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Bloomage Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bloomage Biotechnology Comparisons
Competitors of Bloomage Biotechnology
Bloomage Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fidia Farma, Lifecore, Contipro, Qingdao Kangyuan Pharmaceutica and Altergon Italia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Proprietary hyaluronic acid treatments and derivatives are developed.
|
|
| domain | founded_year | HQ Location |
Hyaluronan-based products for biomedical applications are developed.
|
|
| domain | founded_year | HQ Location |
Manufacturer of hyaluronic acid-based products
|
|
| domain | founded_year | HQ Location |
Operates as a CDMO specializing in hyaluronidase manufacturing.
|
|
| domain | founded_year | HQ Location |
Develops and manufactures pharmaceutical products and medical devices for clients.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bloomage Biotechnology
Frequently Asked Questions about Bloomage Biotechnology
When was Bloomage Biotechnology founded?
Bloomage Biotechnology was founded in 1998.
Where is Bloomage Biotechnology located?
Bloomage Biotechnology is headquartered in Jinan, China. It is registered at Jinan, Shandong, China.
Who is the current CEO of Bloomage Biotechnology?
Zhao Yan is the current CEO of Bloomage Biotechnology.
How many employees does Bloomage Biotechnology have?
As of Dec 31, 2024, the latest employee count at Bloomage Biotechnology is 4,440.
What is the annual revenue of Bloomage Biotechnology?
Annual revenue of Bloomage Biotechnology is $727.46M as on Dec 31, 2024.
What does Bloomage Biotechnology do?
Founded in 1998 in Jinan, China, operations are focused on the biotechnology sector, where hyaluronic acid and pharmaceutical products are produced. Additional manufacturing includes cosmetic and food-grade products, as well as bioactive materials. Technical support is provided to clients. The company serves global markets through its domain, bloomagebioactive.com, with leadership held by CEOs Zhao Yan and Xue Kun Jin.
Who are the top competitors of Bloomage Biotechnology?
Bloomage Biotechnology's top competitors include Lifecore, Fidia Farma and Contipro.
Is Bloomage Biotechnology publicly traded?
Yes, Bloomage Biotechnology is publicly traded on SSE under the ticker symbol 688363.
How many acquisitions has Bloomage Biotechnology made?
Bloomage Biotechnology has made 1 acquisition, including Beijing Yierkang Bioengineering.
What is Bloomage Biotechnology's ticker symbol?
The ticker symbol of Bloomage Biotechnology is 688363 on SSE.